Antibacterial lipid liquid crystalline nanoparticles – synthesis and optimization by central composite design
Source abstract
Abstract
The rise of antibiotic-resistant bacteria demands new antimicrobial strategies. Glyceryl monolaurate (GML) shows antibacterial activity against Gram-positive bacteria like S. aureus but is ineffective against Gram-negative E. coli due to its outer membrane. GML’s limited solubility and susceptibility to bacterial lipases hinder its direct use. This study developed glyceryl monooleate (GMO) lipid liquid crystalline nanoparticles (LLCNPs) incorporating GML to enhance its stability and efficacy. Using a central composite design (CCD), an optimal GMO:GML:F127 mass ratio of 26.5:3.5:1.5 was achieved. Characterization via dynamic light scattering (DLS), small angle X-ray scattering (SAXS), and cryo-transmission electron microscopy (cryo-TEM) confirmed the formation of bicontinuous cubic phase nanoparticles (Pn3m space group) with hydrophobic, hydrophilic, and amphiphilic regions, enabling the incorporation of diverse agents and the presence of sponge-like nanoparticles. The optimized LLCNPs inhibited S. aureus growth at concentrations ≥10 µg/mL by disrupting its membrane potential but showed no activity against E. coli. Cytotoxicity studies indicated that GML incorporation did not significantly affect cell viability compared to pure GMO LLCNPs. This nanoparticle system offers a biocompatible solution for treating Gram-positive bacterial infections and may synergize with existing antibiotics, warranting further investigation into its mechanisms and therapeutic potential.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Surfactants and Colloidal Systems · Advancements in Transdermal Drug Delivery · Lipid Membrane Structure and Behavior
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
NanoBioMedical Centre, Adam Mickiewicz University
Department of Biomedical Physics, Faculty of Physics, Adam Mickiewicz University
Funding
National Science Centre, Poland · Research University – Excellence Initiative
References (74)
Show source-provided references
1. World Health Organization (WHO). The WHO AWaRe (Access Watch Reserve) antibiotic book. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO. Available from: https://www.who.int/publications/i/item/9789240062382
2. 10.4018/978-1-6684-5619-4.ch00510.4018/978-1-6684-5619-4.ch005 ↗
3. 10.59118/NLKD483110.59118/NLKD4831 ↗
4. 10.3389/bjbs.2023.1138710.3389/bjbs.2023.11387 ↗
5. 10.1016/S0140-6736(21)02724-010.1016/S0140-6736(21)02724-0 ↗
6. 10.1016/j.ejps.2021.10610310.1016/j.ejps.2021.106103 ↗
7. 10.47743/jemb-2022-6610.47743/jemb-2022-66 ↗
8. 10.1021/acs.biochem.5b0010910.1021/acs.biochem.5b00109 ↗
9. 10.1002/jsfa.276410.1002/jsfa.2764 ↗
10. 10.1186/s40779-021-00343-210.1186/s40779-021-00343-2 ↗
11. 10.1007/s11033-023-08557-410.1007/s11033-023-08557-4 ↗
12. 10.3389/fmicb.2023.117041810.3389/fmicb.2023.1170418 ↗
13. 10.1002/cben.20210005010.1002/cben.202100050 ↗
14. 10.1021/acs.jpclett.0c0113810.1021/acs.jpclett.0c01138 ↗
15. 10.1021/acs.langmuir.9b0024410.1021/acs.langmuir.9b00244 ↗
16. 10.1128/JB.00743-1210.1128/JB.00743-12 ↗
17. 10.1017/S003358350800472110.1017/S0033583508004721 ↗
18. 10.1371/journal.pone.004035010.1371/journal.pone.0040350 ↗
19. 10.1371/journal.pone.012028010.1371/journal.pone.0120280 ↗
20. 10.1128/AAC.03672-1410.1128/AAC.03672-14 ↗
21. 10.1128/AAC.01151-0910.1128/AAC.01151-09 ↗
22. 10.1128/JB.182.9.2668-2671.200010.1128/JB.182.9.2668-2671.2000 ↗
23. 10.1016/j.colsurfb.2018.06.02510.1016/j.colsurfb.2018.06.025 ↗
24. 10.1016/j.biopha.2023.11463410.1016/j.biopha.2023.114634 ↗
25. 10.1007/s11095-022-03428-210.1007/s11095-022-03428-2 ↗
26. 10.1016/j.ijpharm.2018.10.05710.1016/j.ijpharm.2018.10.057 ↗
27. 10.1016/j.chemphyslip.2020.10502810.1016/j.chemphyslip.2020.105028 ↗
28. 10.1021/la010161w10.1021/la010161w ↗
29. 10.1107/S002188989200976210.1107/S0021889892009762 ↗
30. 10.1080/10408398.2011.57046310.1080/10408398.2011.570463 ↗
31. 10.1371/journal.pone.017869110.1371/journal.pone.0178691 ↗
32. 10.3389/fmicb.2017.0069510.3389/fmicb.2017.00695 ↗
33. 10.1128/AAC.00910-2010.1128/AAC.00910-20 ↗
34. 10.1016/j.bios.2017.09.03610.1016/j.bios.2017.09.036 ↗
35. 10.1021/jp980553k10.1021/jp980553k ↗
36. 10.1111/j.1365-2818.2006.01544.x10.1111/j.1365-2818.2006.01544.x ↗
37. 10.1179/2047773215Y.000000003010.1179/2047773215Y.0000000030 ↗
38. 10.3934/microbiol.2018.3.48210.3934/microbiol.2018.3.482 ↗
39. 10.1016/j.jiph.2021.10.02010.1016/j.jiph.2021.10.020 ↗
40. 10.3389/fmicb.2018.0292810.3389/fmicb.2018.02928 ↗
41. 10.1002/ddr.2145710.1002/ddr.21457 ↗
42. 10.1371/journal.ppat.100421910.1371/journal.ppat.1004219 ↗
43. 10.4161/mge.2308910.4161/mge.23089 ↗
44. 10.1080/07391102.2018.143940410.1080/07391102.2018.1439404 ↗
45. 10.1007/978-3-319-46718-4_1010.1007/978-3-319-46718-4_10 ↗
46. 10.3390/polym1316260710.3390/polym13162607 ↗
47. 10.1186/s12951-020-00604-710.1186/s12951-020-00604-7 ↗
48. 10.1039/c8sm02634c10.1039/c8sm02634c ↗
49. 10.1039/c4sm02296c10.1039/c4sm02296c ↗
50. 10.1186/s12951-021-00913-510.1186/s12951-021-00913-5 ↗
51. 10.1021/acsomega.1c0679610.1021/acsomega.1c06796 ↗
52. 10.1021/la504295v10.1021/la504295v ↗
53. 10.1016/j.cocis.2007.05.00210.1016/j.cocis.2007.05.002 ↗
54. 10.1039/c0sm01410a10.1039/c0sm01410a ↗
55. 10.1002/adfm.20190400710.1002/adfm.201904007 ↗
56. 10.1016/j.jcis.2020.09.08110.1016/j.jcis.2020.09.081 ↗
57. 10.1039/d3sm00578j10.1039/d3sm00578j ↗
58. 10.1039/c0cp01029d10.1039/c0cp01029d ↗
59. 10.1021/nl050678i10.1021/nl050678i ↗
60. 10.1016/s0142-9612(99)00126-x10.1016/s0142-9612(99)00126-x ↗
61. 10.1021/la060295f10.1021/la060295f ↗
62. 10.1038/ncomms991510.1038/ncomms9915 ↗
63. 10.1016/j.drudis.2016.01.00410.1016/j.drudis.2016.01.004 ↗
64. 10.2147/IJN.S26506110.2147/IJN.S265061 ↗
65. 10.1021/acs.molpharmaceut.2c0043910.1021/acs.molpharmaceut.2c00439 ↗
66. 10.1039/C3TX50075F10.1039/C3TX50075F ↗
67. 10.1034/j.1600-0463.2001.d01-131.x10.1034/j.1600-0463.2001.d01-131.x ↗
68. 10.1007/s11745-006-5048-z10.1007/s11745-006-5048-z ↗
69. 10.2754/avb20118001002910.2754/avb201180010029 ↗
70. 10.1002/ejlt.20130017110.1002/ejlt.201300171 ↗
71. 10.1002/smll.20230505210.1002/smll.202305052 ↗
72. 10.1093/femsec/fiac01110.1093/femsec/fiac011 ↗
73. 10.1021/bi300645n10.1021/bi300645n ↗
74. 10.1016/j.bmcl.2013.06.08210.1016/j.bmcl.2013.06.082 ↗